534 related articles for article (PubMed ID: 9811310)
1. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).
Taketo MM
J Natl Cancer Inst; 1998 Nov; 90(21):1609-20. PubMed ID: 9811310
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 inhibitors in tumorigenesis (part I).
Taketo MM
J Natl Cancer Inst; 1998 Oct; 90(20):1529-36. PubMed ID: 9790545
[TBL] [Abstract][Full Text] [Related]
3. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
4. Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer.
Rao M; Yang W; Seifalian AM; Winslet MC
Int J Colorectal Dis; 2004 Jan; 19(1):1-11. PubMed ID: 12783255
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 and gastrointestinal cancer.
Mann JR; DuBois RN
Cancer J; 2004; 10(3):145-52. PubMed ID: 15285921
[TBL] [Abstract][Full Text] [Related]
6. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
7. COX-2 inhibitors--is there cause for concern?
Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
[No Abstract] [Full Text] [Related]
8. [Clinical application of cyclooxygenase-2 inhibitors].
Dzielska-Olczak M; Olczak S
Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
Moran EM
J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
[TBL] [Abstract][Full Text] [Related]
10. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
Fiorucci S; Meli R; Bucci M; Cirino G
Biochem Pharmacol; 2001 Dec; 62(11):1433-8. PubMed ID: 11728379
[TBL] [Abstract][Full Text] [Related]
11. Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma.
Buskens CJ; Ristimäki A; Offerhaus GJ; Richel DJ; van Lanschot JJ
Scand J Gastroenterol Suppl; 2003; (239):87-93. PubMed ID: 14743889
[TBL] [Abstract][Full Text] [Related]
12. COX selectivity and animal models for colon cancer.
Oshima M; Taketo MM
Curr Pharm Des; 2002; 8(12):1021-34. PubMed ID: 11945149
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors.
Richter M; Weiss M; Weinberger I; Fürstenberger G; Marian B
Carcinogenesis; 2001 Jan; 22(1):17-25. PubMed ID: 11159736
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
15. COX-2 inhibition and colorectal cancer.
Koehne CH; Dubois RN
Semin Oncol; 2004 Apr; 31(2 Suppl 7):12-21. PubMed ID: 15252926
[TBL] [Abstract][Full Text] [Related]
16. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of aspirin-like drugs.
Vane JR; Botting RM
Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):2-10. PubMed ID: 9219313
[TBL] [Abstract][Full Text] [Related]
18. COX-2 and colon cancer: potential targets for chemoprevention.
Fournier DB; Gordon GB
J Cell Biochem Suppl; 2000; 34():97-102. PubMed ID: 10762021
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
Sheng H; Shao J; Kirkland SC; Isakson P; Coffey RJ; Morrow J; Beauchamp RD; DuBois RN
J Clin Invest; 1997 May; 99(9):2254-9. PubMed ID: 9151799
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in inducible cyclooxygenase (COX-2) inhibition.
de Leval X; Delarge J; Somers F; de Tullio P; Henrotin Y; Pirotte B; Dogné JM
Curr Med Chem; 2000 Oct; 7(10):1041-62. PubMed ID: 10911017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]